Piper Sandler Posts Record Q1 Revenues as DCM Surges, M&A Slows
Piper Sandler reported record Q1 revenues driven by robust debt capital markets advisory and increased bank hedging activity despite a slowdown in large M&A deal closures. Equity capital markets captured outsized Healthcare market share, though management cautions this level of performance is unlikely to persist into Q2.
1. Q1 Financial Performance
Piper Sandler delivered record first-quarter revenues driven by strong debt capital markets advisory and heightened bank hedging activity amid rate volatility. While Debt Capital Markets advisory led growth, overall advisory revenues were tempered by fewer large bank M&A closings.
2. Bank M&A and Hedging
The firm completed a meaningful number of smaller bank M&A transactions but noted a deceleration in announced large deals compared with the prior quarter. Its derivatives desk experienced elevated hedging volumes as banks adjusted positions against fluctuations in the forward rate curve.
3. Equity Capital Markets Strength
Piper Sandler captured outsized market share in healthcare equity capital markets, buoyed by several high-fee biotech transactions. Management warned that this exceptional ECM performance is unlikely to be sustained through Q2 given typical market share normalization.
4. Advisory and Non-M&A Segments
Debt Capital Markets advisory was the standout performer, with restructuring and private capital advisory providing solid support. Management expects sequential advisory fees to decline as macro uncertainty slows sponsor deal launches in the near term.